02.20.26 -- Deciding When Research Grade Raw Materials Are Sufficient

Navigate the complexities of biotech innovation by exploring how AI, the GLP-1 revolution, and shifting global trial trends are redefining the path to safer, more effective patient treatments.

Enabling sites to focus solely on critical data facilitates faster data entry, reduces queries, and fosters better relationships between sponsors, CROs, and sites.

In this 4-part series, learn about AI-driven methods that streamline data mapping and highlight critical issues that allow clinical teams to focus on what truly matters.

Qualifying raw materials is an investment, but mimicking the manufacturing process at small scales lowers the risk of throwing out material because it doesn't work at large ones, Lawrence Thompson said during this segment of Cell & Gene Live "Viability On The Line."

Commercializing advanced therapeutics requires overcoming regulatory, logistical, and financial hurdles. Learn how to coordinate supply chains and implement adaptive strategies for long-term commercial success.